LicianPro

INTI stock

Inhibitor Therapeutics Inc (INTI) short interest & short volume · 0.0% of float short

Inhibitor Therapeutics Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

INTI short interest rose 100.0% to 320 shares in the Oct 30, 2026 report (0.0% of float, 1.0 days to cover).

Short interest

Official, twice monthly · settled Oct 30, 2026

Shares short
320
prior 0
% of float
0.0%
float 77.1M
Days to cover
1.0
avg vol 30K
Change vs prior report
+100.0%

2 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

INTI short interest by FINRA report (last 2) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 30, 2026320$31+100.0%0.0%1.0$0.10
Jul 31, 20265K$3720.0%0.0%1.0$0.08

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 30, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

No FINRA daily short volume on file for INTI yet.

Short squeeze score (model)

Price since settlement: -17.5%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

INTI's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · INTI overview

Healthcare peers with similar quant ratings

INTI among 536 rated Healthcare stocks (Lician quant rating, Nov 19, 2026). How the rating works

INTI short interest FAQ

What is INTI's short interest?

Inhibitor Therapeutics Inc (INTI) had 320 shares sold short and not yet covered in FINRA's Oct 30, 2026 settlement report, 0.0% of its 77.1M-share float.

How many days to cover does INTI have?

1.0 days: 320 shares short divided by an average daily volume of 30K for the Oct 30, 2026 period.

Is INTI short interest rising or falling?

INTI short interest rose (+100.0%) from 0 to 320 shares in the Oct 30, 2026 report.

Is INTI a short squeeze candidate?

Lician's squeeze watch scores INTI 18 out of 100 (low) from the Oct 30, 2026 report: short interest % of float 0/40, days to cover 2.5/25, change in short interest vs prior report 15/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What is INTI's market cap?

Inhibitor Therapeutics Inc (INTI) market cap is $13.3M on the latest cached fundamentals snapshot.

Where is INTI short volume listed?

Cached FINRA short volume for Inhibitor Therapeutics Inc (INTI) is listed at https://lician.com/short-interest/inti.

Not investment advice. Figures as filed or reported, not a live feed.